Cafepharma Today

November 4 2024 - AstraZeneca says experimental obesity pill safe and tolerable in early-stage trial
AstraZeneca says experimental obesity pill safe and tolerable in early-stage trial
50% of US drug shortages last at least 2 years: ASHP
Pharmas ask appeals court to reconsider IRA lawsuits
Wegovy reduces all-cause admissions: 3 study findings
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

The Genentech Guessing Game - What Will Roche Offer Next?
Seeking Alpha
Thursday, August 21, 2008 - 9:02pm
tags:
DNA analysis heralds a health care revolution
Fortune
Thursday, August 21, 2008 - 9:01pm
tags:
PDL BioPharma's Partnership Makes Sense
Motley Fool
Thursday, August 21, 2008 - 5:54pm
tags:
Johnson & Johnson Gets Rejected
Motley Fool
Thursday, August 21, 2008 - 5:50pm
tags:
Congressmen demand Merck, Schering-Plough supply info on possible Vytorin cancer risk
Yahoo/AP
Thursday, August 21, 2008 - 5:34pm
tags:
A Gardasil Gotcha
Motley Fool
Thursday, August 21, 2008 - 5:22pm
tags:
For Abbott, Diversity Remains Paramount
Yahoo/TheStreet.com
Thursday, August 21, 2008 - 5:18pm
tags:
Abbott to cut 1,000 jobs from diagnostic unit
Yahoo/AP
Thursday, August 21, 2008 - 5:14pm
tags:
Genzyme, PTC Therapeutics Cystic Fibrosis Drug Relieves Symptom
Bloomberg
Thursday, August 21, 2008 - 12:07pm
tags:
Bristol-Myers Ponies Up for Elotuzumab
Seeking Alpha
Thursday, August 21, 2008 - 12:06pm
tags:
Why I'm Buying Amylin Now
Seeking Alpha
Thursday, August 21, 2008 - 12:05pm
tags:
GlaxoSmithKline to Disclose Grants to Hospitals, Patient Groups
WSJ Online
Thursday, August 21, 2008 - 12:04pm
tags:
Lilly releases more favorable study results for cardio drug prasugrel, which awaits FDA OK
Yahoo/AP
Thursday, August 21, 2008 - 12:03pm
tags:
Abbott streamlining plan to save more than $150 mln a year
Marketwatch
Thursday, August 21, 2008 - 12:02pm
tags:
Alpharma Hurt by Medco as Insurers Balk at Pain Patch
Bloomberg
Thursday, August 21, 2008 - 12:00pm
tags:
P&G to License Noven's Patch for Women's Sex Drive
Bloomberg
Thursday, August 21, 2008 - 11:59am
tags:
Merck Cancer Shot May Not Be Economical for All Women
Bloomberg
Thursday, August 21, 2008 - 11:58am
tags:
Eli Lilly reports statistically superior results from Phase III head-to-head TRITON-TIMI 38 study - Quick Facts
RTT News
Thursday, August 21, 2008 - 11:56am
tags:
Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
Yahoo
Thursday, August 21, 2008 - 11:55am
tags:
FDA asks Johnson & Johnson for more information on Doribax
Marketwatch
Thursday, August 21, 2008 - 9:59am
tags:

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

How Field Reimbursement Services Help Overcome Coverage Barriers and Improve Patient Outcomes
Drug Channels
Eli Lilly's Earnings
In the Pipeline
The Choice
In the Pipeline
Drug Channels News Roundup, October 2024: Humira Price War Update, PA vs. Providers, IRA vs. Physicians, My AI Podcast, New DCI Jobs, and Dr. G on Copayments
Drug Channels
GLP-1 For Everything
In the Pipeline
No More Delays: Accelerating Therapy Starts by Embedding Hub Services in Provider Workflows
Drug Channels
A Pfight at Pfizer
In the Pipeline
Clinical Trial Volunteers, And Others
In the Pipeline
The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions
Drug Channels

Latest Jobs

Pharmaceutical Sales Customer Engagement, CNS - Morgantown, WV
Morgantown, West Virginia, 26501
Otsuka
Territory Manager, Medical Dermatology - Omaha, NE
Julian, Nebraska, 68379
Sun Pharmaceutical Industries, Inc.
Pharmaceutical Sales Customer Engagement- Tampa
Tampa, Florida, 33646
Otsuka
Pharmaceutical Sales Customer Engagement- Washington, DC
Washington, District of Columbia, 20022
Otsuka
Pharmaceutical Sales Customer Engagement - Eugene, OR
Eugene, Oregon, 97403
Otsuka
Pharmaceutical Sales Customer Engagement - Atlanta East, GA
Atlanta, Georgia, 30383
Otsuka
Pharmaceutical Sales Customer Engagement- Columbus, OH
Columbus, Ohio, 43224
Otsuka
Pharmaceutical Sales Customer Engagement, CNS - Baltimore S, MD
Baltimore, Maryland, 21276
Otsuka
Pharmaceutical Sales Customer Engagement, CNS - Allentown, PA
Allentown, Pennsylvania, 18103
Otsuka
Territory Manager, Medical Dermatology - Sacramento, CA
Clarksburg, California, 95612
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information